Extracorporeal Membrane Oxygenation Machine Market Size

  • Report ID: 5525
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Extracorporeal Membrane Oxygenation Machine Market Outlook:

Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 487.67 million in 2025 and is set to exceed USD 771.96 million by 2035, registering over 4.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of extracorporeal membrane oxygenation machine is estimated at USD 508.3 million.

The market's growth can be ascribed to the rising prevalence of respiratory diseases. Respiratory diseases such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, and pneumonia are on the rise worldwide. Therefore, extracorporeal membrane oxygenation machines, which provide vital life support to patients with compromised lung function, have witnessed a substantial surge. According to the World Health Organization, in November 2024, almost 380 million people were suffering from chronic obstructive pulmonary disease.

Traditional ventilator support has been proven to be insufficient in severe respiratory failure cases. The extracorporeal membrane oxygenation machine provides advanced respiratory assistance by oxygenating the blood outside the body. This makes the ECMO machine a popular choice amongst the doctors, further bolstering the market growth.


Extracorporeal Membrane Oxygenation Machine Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of extracorporeal membrane oxygenation machine is estimated at USD 508.3 million.

The global extracorporeal membrane oxygenation machine market size crossed USD 487.67 million in 2025 and is likely to register a CAGR of more than 4.7%, exceeding USD 771.96 million revenue by 2035.

Asia Pacific extracorporeal membrane oxygenation machine market will hold more than 36% share by 2035, driven by partnerships, technology transfer, and rising incidence of respiratory diseases.

Key players in the market include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Xenios AG, Microport Scientific Corporation, Eurosets S.r.l., Johnson & Johnson, Abbott, Fresenius Medical Care.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos